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Background
Incidence of hepatitis C virus (HCV) induced hepatocel-
lular carcinoma (HCC) has been increasing in many
developed countries including the United States and
Europe during the recent years. Although many efforts
have been made to understand the pathogenesis, the
picture of its progression still remains elusive.
Materials and methods
We developed a systematic approach to identify deregu-
lated biological networks in HCC by integrating gene
expression profiles [1] with high-throughput protein-
protein interaction data [2]. Samples were grouped into
five disease stages including normal, cirrhotic, dysplastic,
early and advanced HCC. For each pair of consecutive
stages, we compared gene expressions and then mapped
these measures to the protein interaction network.
Responsive subnetworks were then identified from these
node weighted networks. The searching algorithm is
adapted from a previous study [3], which expands the
seed graphs under constrains of several parameters.
Results
Four networks were identified including precancerous
networks (normal-cirrhosis and cirrhosis-dysplasia) and
cancerous networks (dysplasia-early HCC, early-
advanced HCC). A summary of these networks is shown
in Table 1. An independent dataset was used for net-
work validation. Statistical significance of these networks
was assessed within three hypotheses. Little overlap was
observed between precancerous and cancerous net-
works, in contrast to a substantial overlap within pre-
cancerous or cancerous networks. Network functions
were annotated with Gene Ontology biological process
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Table 1 Overview of the responsive networks.
Network #Genes #Interactions #DEGs
* #Hub interactions
†
Normal- cirrhosis 55 67 53 (96.3%) 42 (62.7%)
Cirrhosis- dysplasia 38 50 37 (97.4%) 35 (70.0%)
Dysplasia -early HCC 60 65 53 (88.3%) 37 (56.9%)
Early- advanced HCC 68 98 59 (86.8%) 79 (80.6%)
*Differentially expressed genes (DEGs) were identified as genes with up or down regulation fold change ≥ 2 and student t test P value ≤ 0.01.
†Hub interaction number refers to the total number of interactions involving hub genes.
‡Hub genes were defined to have at least 5 interactions in each network.
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analysis. Significant functions were then assembled into
a module map in temporal order. The apoptosis gene
ZBTB16 was highlighted by examining the module map,
which shows a negative expression pattern with c-myc.
Network analysis led to the identifications of key genes
and pathways by developmental stage, such as LCK sig-
naling pathways in cirrhosis, MMP genes and TIMP
genes in dysplastic liver, and CDC2-mediated cell cycle
signaling in early and advanced HCC. CDC2, a cell cycle
regulatory gene, is particularly interesting because it is a
hub protein of the module that shows correlative pat-
tern with cancer progression.
Conclusions
Our study uncovers a temporal spectrum of functional
deregulation and prioritizes key genes and pathways in
the progression of HCV induced HCC. Despite the con-
firmation of much knowledge in the pathogenesis of this
disease, these findings also provide additional insights
for further investigations.
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